More info
Description
Ingredients Betahistine dihydrochloride 24 mg Excipients: microcrystalline cellulose, lactose (milk sugar), corn starch, polyvinylpyrrolidone (povidone), sodium carboxymethyl starch (primogel), talc, colloidal silicon dioxide (aerosil). Pharmacological action Synthetic analogue of histamine. It acts like histamine mainly on histamine H1 receptors. Causes expansion of precapillaries, in particular, facilitates microcirculation in the maze. In addition, betahistine regulates endolymph pressure in the labyrinth and cochlea, leading to clinical improvement in vertigo of various etiologies. Reduces the frequency and intensity of dizziness, reduces tinnitus, improves hearing in cases of its decline. Increases the tone of the smooth muscles of the bronchi, gastrointestinal tract. May cause increased secretion of gastric juice.
Dosage and administration
Single dose - 8-16 mg, the multiplicity of reception - 3 times / day. The treatment is carried out for a long time. Precautions During the period of treatment may worsen psoriasis. With pheochromocytoma, propranolol can be used only after taking an alpha blocker. After a long course of treatment, propranolol should be discontinued gradually, under the supervision of a physician. Against the background of treatment with propranolol, IV administration of verapamil, diltiazem should be avoided. A few days before anesthesia, you must stop taking propranolol or pick up a remedy for anesthesia with minimal negative inotropic effects. Influence on the ability to drive vehicles and control mechanisms In patients whose activities require increased attention, the question of the use of propranolol on an outpatient basis should be addressed only after evaluating the individual response of the patient. Side effect On the part of the digestive system: slight nausea, feeling of heaviness in the epigastrium are possible. Allergic reactions: in some cases - skin rash, itching, urticaria. Specific guidance With caution should be used in patients with gastric ulcer or duodenal ulcer in history, in the II and III trimesters of pregnancy, as well as in children. It must be borne in mind that the desired clinical effect is achieved after several months of treatment.With dyspeptic symptoms, betahistine is recommended to be taken during or after a meal. Use during pregnancy and breastfeeding. It is not recommended to use it in the first trimester of pregnancy and during lactation. Caution should be used in the II and III trimesters of pregnancy. Type: Medicine Quantity in the package, pcs: 20 Shelf life: 24 months Active ingredient: Betahistine (Betahistine) Route of administration: Oral Vacation order: Prescription Release form: Prescription Storage conditions: In a dry place, In a dark place, Keep out of reach of children Maximum storage temperature, ° С: 25 Pharmacological group: N07CA01 Betahistine Minimum age: 18 yearsActive ingredients
Betahistine
Release form
Pills
Composition
Betahistine dihydrochloride 24 mg Auxiliary substances: microcrystalline cellulose, lactose (milk sugar), corn starch, polyvinylpyrrolidone (povidone), sodium carboxymethyl starch (primogel), talc, colloidal silicon dioxide (aerosil).
Pharmacological effect
Synthetic analogue of histamine. It acts like histamine mainly on histamine H1 receptors. Causes expansion of precapillaries, in particular, facilitates microcirculation in the maze. In addition, betahistine regulates endolymph pressure in the labyrinth and cochlea, leading to clinical improvement in vertigo of various etiologies. Reduces the frequency and intensity of dizziness, reduces tinnitus, improves hearing in cases of its decline. Increases the tone of the smooth muscles of the bronchi, gastrointestinal tract. May cause increased secretion of gastric juice.
Indications
Meniere's disease. syndromes characterized by dizziness, tinnitus and / or progressive hearing loss, incl. dropsy of the labyrinth of the inner ear, vestibular and labyrinth disorders (including dizziness, noise and ear pain, headache, nausea, vomiting, hearing loss), vestibular neuritis, labyrinthitis, benign positional dizziness (including after neurosurgical operations). vertebrobasilar insufficiency, post-traumatic encephalopathy, cerebral atherosclerosis (as part of complex therapy).
Contraindications
Pheochromocytoma, gastric ulcer and duodenal ulcer in the acute phase, bronchial asthma, I trimester of pregnancy, hypersensitivity to betahistine.
Use during pregnancy and lactation
Not recommended for use in the first trimester of pregnancy and lactation.Caution should be used in the II and III trimesters of pregnancy.
Dosage and administration
Single dose - 8-16 mg, the multiplicity of reception - 3 times / day. The treatment is carried out for a long time.
Side effects
On the part of the digestive system: slight nausea, feeling of heaviness in the epigastrium are possible. Allergic reactions: in some cases - skin rash, itching, urticaria.
special instructions
On the part of the digestive system: slight nausea, feeling of heaviness in the epigastrium are possible. Allergic reactions: in some cases - skin rash, itching, urticaria.